Ultrastructural and immunoelectron microscopic study of three unusual plurihormonal pituitary adenomas

Ultrastructural Pathology

Volumn 23, Issue 3, 1999, Pages 141-148

  Vidal, Sergio ^a   Syro, Luis ^b   Horvath, Eva ^a   Uribe, Humberto ^c   Kovacs, Kalman ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b HOSPITAL PABLO TOBÓN URIBE   (Colombia)

^c UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

Human; Immunoelectron microscopy; Pituitary adenoma; Plurihormonality; Ultrastructure

Indexed keywords

GROWTH HORMONE; PROLACTIN; THYROTROPIN;

ACROMEGALY; ALPHA CHAIN; ARTICLE; CELL LINE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPROLACTINEMIA; HYPOPHYSIS ADENOMA; IMMUNOCYTOCHEMISTRY; IMMUNOELECTRON MICROSCOPY; IMMUNOREACTIVITY; PHENOTYPE; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY;

ACROMEGALY; ADENOMA; ADULT; CYTOPLASMIC GRANULES; ENDOPLASMIC RETICULUM, ROUGH; FEMALE; GLYCOPROTEIN HORMONES, ALPHA SUBUNIT; GOLGI APPARATUS; HUMAN GROWTH HORMONE; HUMANS; MALE; MICROSCOPY, IMMUNOELECTRON; PITUITARY NEOPLASMS; PROLACTIN; THYROTROPIN;

EID: 0032998046     PISSN: 01913123     EISSN: None     Source Type: Journal    
DOI: 10.1080/019131299281635     Document Type: Article

References (41)

1. Landolt AM. Ultrastructure of human sella tumors: correlations of the clinical findings and morphology. Acta Neurochir (Wien) suppl. 1975;22:1-167.
2. Kovacs K, Horvath E, Ezrin C. Pituitary adenomas. Pathol Annu. 1977;12:341-382.
3. Horvath E, Scheithauer BW, Kovacs K, Lloyd RV. Regional neuropathology: hypothalamus and pituitary. In: Graham DI, Lantos PL (eds). Greenfield's Neuropathology, ed. 6. London: Arnold; 1997:1007-1094.
4. Horvath E, Kovacs K. The adenohypophysis. In: Kovacs K, Asa SL (eds). Functional Endocrine Pathology, ed 2. Malden, MA: Blackwell Science; 1998:247-281.
5. Horvath E, Kovacs K, Scheithauer BW, et al. Pituitary adenomas producing growth hormone, prolactin, and one or more glycoprotein hormones: a histologic, immunohistochemical, and ultrastructural study of four surgically removed tumors. Ultrastruct Pathol. 1983;5:171-183.
6. Scheithauer BW, Horvath E, Kovacs K, Laws ER Jr, Randall RV, Ryan N. Plurihormonal pituitary adenomas. Semin Diagn Pathol. 1986;3:69-82.
7. Hsu SM, Raine L, Fanger H. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase techniques. Am J Clin Pathol. 1981;75:816-821.
8. Kovacs K, Lloyd RV, Horvath E, et al. Silent somatotroph adenomas of the human pituitary: a morphologic study of three cases including immunocytochemistry, electron microscopy, in vitro examination, and in situ hybridization. Am J Pathol. 1989;134:345-353.
9. Kovacs K, Stefaneanu L, Horvath E, et al. Effects of dopamine agonist medication on prolactin producing pituitary adenomas: a morphologic study including immunocytochemistry, electron microscopy and in situ hybridization. Virchow Arch A Pathol Pathol Anat. 1991;418:439-446.
10. Bendayan M. Double immunocytochemical labeling applying the protein A-gold technique. J Histochem Cytochem. 1982;30:81-85.
11. Bendayan M, Zollinger M. Ultrastructural localization of antigenic sites on fixed tissues applying the protein A-gold technique. J Histochem Cytochem. 1983;31:101-109.
12. Vidal S, Roman A, Moya L. Description of two types of mammosomatotropes in mink (Mustela vison) adenohypophysis: changes in the population of mammosomatotropes under different physiological conditions. Acta Anat. 1997;159:209-217.
13. Vogelstein B, Fearon ER, Hamilton SR, et al. Clonal analysis using recombinant DNA probes from the X-chromosome. Cancer Res. 1987;47:4806-4813.
14. Alexander JM, Biller BM, Bikkal H, Zervas NT, Arnold A, Klibanski A. Clinically nonfunctioning pituitary tumors are monoclonal in origin. J Clin Invest. 1990;86:336-340.
15. Herman, V, Fagin J, Gonsky R, Kovacs K, Melmed S. Clonal origin of pituitary adenomas. J Clin Endocrinol Metab. 1990;71:1427-1433.
16. Schulte HM, Oldfield EH, Allolio B, Katz DA, Berkman RA, Ali IU. Clonal composition of pituitary adenomas in patients with Cushing's disease: determination by X-chromosome inactivation analysis. J Clin Endocrinol Metab. 1991;73:1302-1308.
17. Shimon I, Melmed S. Genetic basis of endocrine disease: pituitary tumor pathogenesis. J Clin Endocrinol Metab. 1997;82:1675-1681.
18. Vallar L, Spada A, Giannattasio G. Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature. 1987;330:566-568.
19. Spada A, Vallar L. G-protein oncogenes in acromegaly. Horm Res. 1992;38:90-93.
20. Oyesiku NM, Evans CO, Brown MR, Blevins LS, Tindall GT, Parks JS. Pituitary adenomas: screening for G alpha q mutations. J Clin Endocrinol Metab. 1997;82:4184-4188.
21. Kovacs K, Horvath E, Stefaneanu L, et al. Pituitary adenoma producing growth hormone and adrenocorticotropin: a histological, immunocytochemical, electron microscopic, and in situ hybridization study. J Neurosurg. 1998;88:1111-1115.
22. Bodner M, Castrillo JL, Theill LE, Deerinck T, Ellisman M, Karin M. The pituitary-specific transcription factor GHF-1 is a homeobox-containing protein. Cell. 1988;55:505-518.
23. Ingraham HA, Chen RP, Mangalam HJ, et al. A tissue-specific transciption factor containing a homeodomain specifies a pituitary phenotype. Cell. 1988;55:519-529.
24. Simmons DM, Voss JW, Ingraham HA, et al. Pituitary cell phenotypes involve cell-specific Pit-1 mRNA translation and synergistic interactions with other classes of transcription factors. Genes Dev. 1990;4:695-711.
25. Chen R, Ingaham HA, Treacy MN, Albert VR, Wilson L, Rosenfeld MG. Autoregulation of pit-1 gene expression mediated by two cis-active promoter elements. Nature. 1990;346:583-586.
26. Sanno N, Teramoto A, Matsuno A, Takekoshi S, Osamura RY, GH and PRL gene expression by nonradioisotopic in situ hybridization in TSH-secreting pituitary adenomas. J Clin Endocrinol Metab. 1995;80:2518-2522.
27. Horvath E, Lloyd RV, Kovacs K. Propylthiouracyl-induced hypothyroidism results in reversible transdifferentiation of somatotrophs into thyroidectomy cells: a morphologic study of the rat pituitary including immunoelectron microscopy. Lab Invest. 1990;63:511-520.
28. Porter TE, Hill JB, Wiles CD, Frawley LS. Is the mammosomatotrope a transitional cell for the functional interconversion of growth hormone- and prolactin-secreting cells? Suggestive evidence from virgin, gestating, and lactating rats. Endocrinology. 1990;127:2789-2794.
29. Frawley LS, Boockfor FR. Mammosomatotropes: presence and functions in normal and neoplastic pituitary tissue. Endocrine Rev. 1991;12:337-355.
30. Bassetti M, Spada A, Arosio M, Vallar L, Brina M, Giannattasio G. Morphological studies on mixed growth hormone (GH) and prolactin (PRL)-secreting human pituitary adenomas: coexistence of GH and PRL in the same secretory granule. J Clin Endocrinol Metab. 1986;62:1093-1100.
31. Felix IA, Horvath E, Kovacs K, Smyth HS, Killinger DW, Dale J. Mammosomatotroph adenoma of the pituitary associated with gigantism and hyperprolactinemia: a morphologic study including immunoelectron microscopy. Acta Neuropathol. 1986;71:76-82.
32. Nikitovitch-Winer MB, Atkin J, Male BE. Colocalization of prolactin and growth hormone within specific adenohypophyseal cells in male, female, and lactating female rats. Endocrinology, 1987;121:625-630.
33. Kovacs K, Horvath E, Losinski EN. Mammosomatotrophs in nontumorous and adenomatous rat pituitaries: an immunoelectron microscopic study. Exp Clin Endocrinol. 1988;7:109-113.
34. Asa SL, Kovacs K, Horvath E, et al. Human fetal adenohypophysis: electron microscopic and ultrastructural immunocytochemical analysis. Neuroendocrinology. 1988;48:423-431.
35. Losinski EN, Horvath E, Kovacs K. Double-labeling immunogold electron-microscopic study of hormonal colocalization in nontumorous and adematous rat pituitary. Am J Anat. 1989;185:236-243.
36. Sasaki F, Iwama Y. Two types of mammosomatotropes in mouse adenohypophysis. Cell Tissue Res. 1989;256:654-648.
37. Kovacs K, Horvath E, Asa SL, Stefaneanu L, Sano T. Pituitary cells producing more than one hormone: human pituitary adenomas. Trends Endocrinol Metab. 1989;1:104-107.
38. Schaufele F, West BL, Baxter JD. Synergistic activation of the rat growth hormone promoter by Pit-1 and the thyroid hormone receptor. Mol Endocrinol. 1992;6:656-665.
39. Holloway JM, Szeto DP, Scully KM, Glass CK, Rosenfeld MG. Pit-1 binding to specific DNA sites as a monomer or dimer determines gene-specific use of a tyrosine-dependent synergy domain. Genes Dev. 1995;9:1992-2006.
40. Drouin J, Lamolet B, Lameonene T, Lanctot C, Trembloy JJ. The PTX family of homeodomain transcription factors during pituitary developments. Mol Cell Endocrinol. 1998;140:31-36.
41. Watkins-Chow DE, Camper SA. How many homeobox genes does it take to make a pituitary gland? Trends Genet. 1998;14:284-290.